Authors: Winn, M Reilly, EB Liu, G Huth, JR Jae, HS Freeman, J Pei, ZH Xin, ZL Lynch, J Kester, J von Geldern, TW Leitza, S DeVries, P Dickinson, R Mussatto, D Okasinski, GF

Citation: M. Winn et al., Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 4. Structure-activity relationship of substituents on the benzene ring of the cinnamide, J MED CHEM, 44(25), 2001, pp. 4393-4403

Authors: Szczepankiewicz, BG Liu, G Jae, HS Tasker, AS Gunawardana, IW von Geldern, TW Gwaltney, SL Wu-Wong, JR Gehrke, L Chiou, WJ Credo, RB Alder, JD Nukkala, MA Zielinski, NA Jarvis, K Mollison, KW Frost, DJ Bauch, JL Hui, YH Claiborne, AK Li, Q Rosenberg, SH

Citation: Bg. Szczepankiewicz et al., New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models, J MED CHEM, 44(25), 2001, pp. 4416-4430

Authors: Jae, HS Winn, M von Geldern, TW Sorensen, BK Chiou, WJ Nguyen, B Marsh, KC Opgenorth, TJ

Citation: Hs. Jae et al., Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ETA antagonists, J MED CHEM, 44(23), 2001, pp. 3978-3984

Authors: Tahir, SK Han, EKH Credo, B Jae, HS Pietenpol, JA Scatena, CD Wu-Wong, JSR Frost, D Sham, H Rosenberg, SH Ng, SC

Citation: Sk. Tahir et al., A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors, CANCER RES, 61(14), 2001, pp. 5480-5485